what are the different glp 1 drugs GLP-1 Drug Comparison in Diabetes and Obesity Treatment Glucagon-like peptide-1 receptor agonists(GLP-1RAs)** GLP-1

healthcare system $380 billion annually

Semaglutide activates (an agonist) the GLP-1 receptor, while tirzepatide is in a new class of dual agonists: it activates (mimics) both the GLP-1 receptor and GIP receptors (Gastric inhibit polypeptide is also known as glucose-dependent insulinotropic polypeptide.) The potency of activation for tirzepatide is 5-fold more for GIPR than GLP1

DIGESTIVE SUPPORT - Formulated with prebiotic fibers, including resistant starch, to support a balanced gut microbiome and promote healthy digestive function BALANCED APPETITE & METABOLISM By supporting GLP-1 activity, it helps regulate appetite and maintain healthy blood sugar levels, contributing to sustained energy and metabolic wellness

North America emerged as the leading regional market, capturing 49.7% of the global share in 2024

SHAKE WELL BEFORE USING

GAN DIO: gubra amylin NASH, diet-induced obese